IRIS
BONANNI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.733
EU - Europa 8.481
AS - Asia 7.199
SA - Sud America 1.370
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
Totale 27.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.494
SG - Singapore 2.832
CN - Cina 2.188
IT - Italia 2.152
IE - Irlanda 1.342
UA - Ucraina 1.143
BR - Brasile 1.115
GB - Regno Unito 808
TR - Turchia 805
SE - Svezia 781
DE - Germania 660
FR - Francia 563
VN - Vietnam 495
IN - India 386
FI - Finlandia 330
RU - Federazione Russa 247
CA - Canada 137
HK - Hong Kong 98
AR - Argentina 88
MX - Messico 77
PL - Polonia 77
JP - Giappone 76
NL - Olanda 73
AT - Austria 66
BD - Bangladesh 61
ES - Italia 54
ZA - Sudafrica 53
CZ - Repubblica Ceca 47
EC - Ecuador 45
IQ - Iraq 43
IR - Iran 30
ID - Indonesia 29
BE - Belgio 26
PK - Pakistan 26
CL - Cile 25
CO - Colombia 25
KR - Corea 25
LU - Lussemburgo 25
VE - Venezuela 21
EU - Europa 19
LT - Lituania 18
PE - Perù 18
MA - Marocco 16
PY - Paraguay 16
UZ - Uzbekistan 15
RO - Romania 14
IL - Israele 13
AE - Emirati Arabi Uniti 12
EG - Egitto 12
CH - Svizzera 10
AU - Australia 9
JO - Giordania 9
TN - Tunisia 9
AZ - Azerbaigian 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
LB - Libano 7
NZ - Nuova Zelanda 7
BO - Bolivia 6
KE - Kenya 6
NO - Norvegia 6
SA - Arabia Saudita 6
UY - Uruguay 6
OM - Oman 5
DZ - Algeria 4
GY - Guiana 4
HU - Ungheria 4
KZ - Kazakistan 4
PA - Panama 4
SN - Senegal 4
BG - Bulgaria 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
SC - Seychelles 3
SM - San Marino 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
ET - Etiopia 2
NG - Nigeria 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
GD - Grenada 1
GH - Ghana 1
Totale 27.921
Salva come PNG Salva come JPEG
Città #
Singapore 2.068
Chandler 1.491
Jacksonville 1.342
Dublin 1.320
Ashburn 732
Princeton 621
Dallas 599
Southend 570
Beijing 555
Izmir 418
Nanjing 407
Los Angeles 294
Dearborn 290
Wilmington 273
Santa Clara 264
The Dalles 242
Cambridge 210
New York 206
Chieti 200
Altamura 195
Munich 191
Ho Chi Minh City 171
Tongling 159
Ann Arbor 144
Nanchang 139
Buffalo 118
Boardman 115
São Paulo 115
Pescara 112
Redondo Beach 112
Rome 112
Hong Kong 95
Milan 87
Hanoi 86
Woodbridge 75
Helsinki 74
Hebei 69
Tianjin 69
Washington 67
Shenyang 61
Warsaw 59
Kunming 57
Brooklyn 54
Turku 54
Tokyo 53
Houston 51
Nuremberg 50
Grevenbroich 49
Hefei 49
Denver 48
London 47
Toronto 46
Jiaxing 44
Montreal 44
Norwalk 44
Belo Horizonte 42
Chicago 42
Changsha 41
Orem 41
Seattle 41
Chennai 36
Stockholm 36
Council Bluffs 35
Jinan 35
Johannesburg 35
Dong Ket 34
Frankfurt am Main 34
Poplar 33
Hangzhou 32
Brno 30
Atlanta 29
Florence 29
Mexico City 28
Vienna 28
Augusta 26
Capurso 26
Amsterdam 25
Biên Hòa 24
Falls Church 24
Rio de Janeiro 24
San Francisco 24
Brussels 23
Lanzhou 23
Phoenix 23
Pune 23
Leawood 22
Mumbai 22
Ardabil 21
Boston 21
Manchester 21
Seoul 21
Changchun 20
Haiphong 20
Naples 20
Paris 20
Brasília 19
Ningbo 19
Baghdad 17
Porto Alegre 17
Querétaro 17
Totale 16.440
Salva come PNG Salva come JPEG
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 468
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 336
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 300
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 267
Pre-trattamento antiematico per Test/terapia all'apomorfina 182
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 158
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 155
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 155
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 151
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 147
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 144
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 143
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 143
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 143
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 142
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 141
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 139
Akinetic crisis in Dementia with Lewy Bodies 137
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 136
Progetto atrofia multisistemica: risultati preliminari. 136
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 135
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 133
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 132
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 131
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 131
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 130
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 129
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 127
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 126
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 126
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 125
Bipallidal lesions induce delayed and progressive parkinsonism 125
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 125
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 124
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 124
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 123
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 122
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 121
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 121
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 120
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 120
Attention network in AD and DLB patients: a resting fMRI study. 120
Improving diagnostic accuracy of DLB: An MRI study 120
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 120
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 119
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 119
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 118
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 118
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 117
Autoscopic phenomena: case report and review of literature. 116
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 115
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 114
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 114
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 114
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 114
Instabilità posturale nel Parkinson non farmaco-responder 113
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 113
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 112
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 111
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 110
Mitochondrial Involvement in Neurodegenerative Dementia 109
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 108
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 108
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 108
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 108
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 107
Pathological Gambling in PD is reduced by Amantadine 107
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 107
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 107
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase 106
Atrofia Multisistemica: approccio diagnostico multidisciplinare 106
Serial analysis of peripheral blood T cell receptor (TCR) V beta repertoire by RT-PCR/SSCP in patients with multiple sclerosis (MS) and healthy controls. 106
Catamenial end-off dose in Parkinson's disease 106
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 105
Dynamics of peripheral blood T cell receptor V beta repertoire in patients with relapsing-remitting multiple sclerosis. 105
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 105
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 105
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 105
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 105
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 104
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 104
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 104
Interictal Heart Rate Variability Analysis Reveals Lateralization of Cardiac Autonomic Control in Temporal Lobe Epilepsy 104
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 103
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 103
The pharmacology of visual hallucinations in synucleinopathies 103
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 103
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel 103
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 102
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 102
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 102
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 102
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 101
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 101
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 101
Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies. 101
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 100
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 100
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 100
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 100
Totale 12.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.013 0 0 0 0 0 324 44 53 132 207 154 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20255.465 303 919 827 146 155 236 254 286 468 348 612 911
2025/20265.974 959 442 1.252 1.654 1.123 544 0 0 0 0 0 0
Totale 28.865